January 18, 2014 -- Alnylam Pharmaceuticals Risk/Yield for 2014
More action to come - Overall, the graphs indicate that this company will have positive activity during the first part of the year. This is one to watch for additional deals that might be coming to the table.
Refer to Reading Graphs for information on interpretation of the graphs. Also, refer to the Global, USA, and other company's graphs on this site for 2013 and compare to market prices for 2013. Questions .... you can always send an email to info@lionessAssociates.com.
Disclosure as of 1/18/2014 - Alnylam Pharmaceuticals (ALNY) is not part of our portfolio at this time.
Disclaimer Reports are provided for information purposes. These reports/graphs do not constitute a recommendation to buy, sell, or hold any security. You are fully responsible for any decisions, investment or otherwise, you make and such decisions are based solely on your circumstances and objectives.
Copyright Issues All attempts are made to ensure that our material is properly sourced by including links to original material. We are in the process ofsecuring rights for 5 stock price graphs from Yahoo's financial web site. If you are aware of a copyright issue on this website, please send an email to info@lionessassociates.com.
